- ENOVIS™ Showcases Next Generation of Medical Technology at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
- Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023
- Enovis™ to Showcase Latest Innovations and Growing Foot & Ankle Portfolio at ACFAS 2023
- Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples
- Enovis to Participate in the 41st Annual J.P. Morgan Healthcare Conference
- Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle
- Enovis Introduces DynaNail Helix™ – a New Twist on Hindfoot Fusions
- Enovis’ ARVIS® Awarded the AAHKS Industry Innovation Award at the 2022 American Academy of Hip and Knee Surgeons Annual Meeting
- Enovis Announces Third Quarter 2022 Results
- Enovis to Participate in Investor Conferences in November
More ▼
Key statistics
On Monday, Enovis Corp (ENOV:NYQ) closed at 50.32, 14.68% above the 52 week low of 43.88 set on Oct 13, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 50.85 |
---|---|
High | 50.85 |
Low | 49.96 |
Bid | 49.50 |
Offer | 51.24 |
Previous close | 50.32 |
Average volume | 675.72k |
---|---|
Shares outstanding | 54.33m |
Free float | 48.01m |
P/E (TTM) | -- |
Market cap | 2.71bn USD |
EPS (TTM) | -0.7322 USD |
Data delayed at least 15 minutes, as of Mar 27 2023 21:10 BST.
More ▼